News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Mark Terry

news@biospace.com

BioSpace News - By Mark Terry
Meet the 'Rock Star of Science' Obsessed With Stopping Alzheimer's 6/23/2017
Survey Says: Here Are the 4 Most-Liked Life Science CEOs 6/23/2017
5 Biotechs Quietly Hitting Unusual Volumes Right Now 6/23/2017
Genentech (RHHBY) Wins No. 1 Top Spot as The Ideal Employer in Life Sciences 6/22/2017
15 In-Demand Life Science Jobs in Northern California 6/22/2017
3 Biotech Stocks That Look Like Apple (AAPL) Did in the 1980s 6/22/2017
Insiders Just Bought $234 Million Worth of These Pharma Stocks 6/22/2017
3 Pharma Stocks Billionaire Izzy Englander Bought Recently 6/22/2017
PAREXEL (PRXL) Sold to Investment Firm in $5 Billion Deal 6/22/2017
Repare Therapeutics Bursts From Stealth Mode With $68 Million and a Team Packed With Industry Alums 6/22/2017
12 Careers for Life Scientists Outside of the Lab 6/22/2017
Novartis AG (NVS) Rejects Trump's Proposition to Create More U.S Jobs 6/22/2017
More Deaths Lead Seattle Genetics (SGEN) to Discontinue Phase III Leukemia Study 6/21/2017
Clovis Oncology (CLVS) Stock Soars as Ovarian Cancer Trial Dazzles 6/21/2017
Massachusetts Biotech Startup Sigilon Launches With $23.5 Million 6/21/2017
Tiny New York Biotech With Ties To Massachusetts, Syntimmune, Gets A $50 Million Boost 6/21/2017
A Look at the 5 Most Profitable Biopharma Companies 6/21/2017
Novartis AG (NVS)'s Next-Generation Eye Drug Works With Fewer Injections Than Rivals 6/21/2017
Warning: These Could be the Top 3 Most Overrated Biotech Stocks 6/20/2017
Faltering Enumeral Biomedical (ENUM) Cuts R&D Staff, Alters Executive Compensation Deal 6/20/2017
Gilead (GILD), Sanofi (SNY) Reportedly Bidding on This $10 Billion Massachusetts Biotech 6/16/2017
Why This Bay Area Biotech Could Be the Best-in-Breed for 2017 6/16/2017
After Bagging Patheon (PTHN) for $7.2 Billion, This Could be Thermo Fisher Scientific (TMO)'s New Target 6/16/2017
What Biogen (BIIB) CFO's Departure Means for Company's M&A Strategy 6/16/2017
Google (GOOG)'s Verily (GOOGL) and Novartis AG (NVS) Jump Into Medicxi's $300 Million Life Science Investment Fund 6/15/2017
UK Charity to Use $638 Million Cash From Merck & Co. (MRK)'s Blockbuster Keytruda to Back R&D 6/15/2017
Up and Coming Scientist Gets Funding for CAR-T Startup CARMA Therapeutics 6/15/2017
Helsinn And MEI Pharma (MEIP) Announce First Patient Dosed In Phase II Dose-Optimization Study Of Pracinostat And Azacitidine In Myelodysplastic Syndrome 6/14/2017
Sanofi (SNY) Commits $673 Million in Biologics 6/14/2017
Why Celgene (CELG) Gets No R-E-S-P-E-C-T, But Should 6/14/2017
Massachusetts Biotech iSpecimen Launches Amazon (AMZN)-Like Marketplace for Scientists 6/14/2017
Why This Tiny New Jersey Biotech Looks Like Oracle in 1986 6/13/2017
What Biogen (BIIB) Wants in Return for Financial Assistance of Its $750,000 a Year Drug 6/13/2017
Disney-Backed Dragonfly Nabs $33 Million From Biotech Bestie Celgene (CELG) 6/13/2017
Effective Immediately: Bristol-Myers Squibb (BMY) Exec to Take the Reins at Kleo 6/12/2017
Sanofi (SNY)'s Rumored Buyout Target Flexion (FLXN) Shows Off Mid-Stage Osteoarthritis Data 6/12/2017
Bristol-Myers Squibb (BMY) Asks for Patience as Takeover Chatter Reemerges Post-ASCO 6/12/2017
NantHealth (NH)'s Patrick Soon-Shiong Expands His Empire With Plans to Open a World-Class Cancer Center This Summer 6/12/2017
16 Questions Top Pharma Applicants Should Ask During the Job Interview 6/9/2017
Smart Biotech Careers for Job Seekers With No PhD 6/9/2017
Investment Group Just Paid $605 Million for This Bay Area Pharma 6/9/2017
Top 10 Life Science Job Trends in 2017 6/9/2017
NewLink Genetics (NLNK) Stock Plunges After Genentech (RHHBY) Bails on $1 Billion+ IDO Deal 6/9/2017
Bristol-Myers Squibb (BMY) Loses $4.3 Billion in Market Value After ASCO Update 6/8/2017
Why This Seattle Biotech's Stock Has More Than Doubled in 8 Months 6/8/2017
The 1 Pharma Stock That Feels Like Microsoft in 1986 6/8/2017
This Small Massachusetts Biotech Soared to a 20-Month High on Its Celgene (CELG)-Partnered Trial 6/8/2017
Bomb Scare Leads to Evacuation at Pfizer (PFE) Plant 6/7/2017
PE Firms Take Out New York's AMRI (AMRI) for $922 Million Cash 6/7/2017
Unknown Nanjing Legend Emerges as a CAR-T Phenom at ASCO 6/7/2017
Bay Area GRAIL's Billion Gamble on the Perfect Cancer Test 6/7/2017
2 Small Biotechs Whose ASCO Presentations Could Kick Stocks Higher 6/6/2017
7 Biotechs and Pharmas That Have the Potential to Double (or More) 6/6/2017
Investors Sigh With Relief as bluebird bio (BLUE), Celgene (CELG)'s CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free 6/5/2017
Down but Not Out, Juno (JUNO) Fights Back with Positive CAR-T Results in its JCAR017 Program 6/5/2017
Stock Tanks as Endocyte (ECYT) Cuts 40% of Workforce, Slashes 2 Clinical Programs 6/5/2017
Spectacular Data Posted for Novartis AG (NVS)'s Next Generation CAR-T Drug 6/2/2017
Why Pfizer (PFE), AstraZeneca PLC (AZN) and Clovis Oncology (CLVS) Aren’t Interested in Tesaro (TSRO) 6/2/2017
10 Biotechs Awaiting FDA Decisions in June 6/2/2017
Novartis AG (NVS) Lays Out R&D Game Plan at Meet and Greet With 30 Execs in Boston 6/2/2017
Meet the 31-Year Old Worth $3 Billion Helping Drug Companies Like Bristol-Myers Squibb (BMY) and Pfizer (PFE) Market in Doctors' Offices 6/2/2017
$8 Billion+ Tesaro (TSRO) is Exploring a Sale But No Serious Suitors are Lining Up Just Yet 6/2/2017
Investors Relieved as Novartis AG (NVS) CEO Seeks Only $5 Billion Bolt-On Acquisitions, Not Huge M&As 6/1/2017
A Look at Gilead (GILD)'s Possible New Drug Strategy 6/1/2017
Why June Could be a Pivotal Month for These 2 Biotechs 5/31/2017
Investors Antsy as Novartis AG (NVS) Mulls Over Selling $50 Billion in Assets 5/31/2017
Germany's Evotec AG (EVTG.F) Plans to Hire Scientists and Execs at New U.S. HQ 5/30/2017
Biogen (BIIB) Loses Yet Another Top Exec 5/30/2017
5 Big Pharmas Facing Catalysts in 2017 5/26/2017
Cannabis Jobs That Require a Life Science Background Are Booming 5/26/2017
Jounce (JNCE)'s Number One Employee Rejoins Constellation Pharma as New CEO 5/26/2017
Journalist Sues FDA for Documents Related to Sarepta (SRPT)'s DMD Drug 5/26/2017
Novartis AG (NVS) to Lay Off 250 Nationwide, With 204 from New Jersey U.S. Headquarters 5/25/2017
Here's What You Need to Know to Get a Clinical Research Job 5/25/2017
Arix Bioscience Gets in on Bay Area Cancer Biotech Harpoon's $45 Million Funding Round 5/25/2017
How Alexion (ALXN) is Making So Much Cash With a Drug That Treats Less Than 11,000 Patients 5/25/2017
3 Biopharma Stocks Billionaire Money Managers Unloaded Recently 5/25/2017
Alexion (ALXN): A Successful Migration of a Biopharma Corporate Data Center to the Cloud 5/25/2017
Alexion (ALXN) Boss Shakes Up Executive Team, Head of R&D Retires, CFO and HR Exec Step Down 5/24/2017
Former Biogen (BIIB) Exec Launches Bain Capital’s First Life Sciences Fund With $750 Million 5/24/2017
6 (Plus 2!) Most Notable ASCO Abstracts So Far 5/24/2017
Biogen (BIIB) Spinoff Bioverativ (BIVV) Takes Out Bay Area's True North in $825 Million Deal 5/24/2017
Bill & Melinda Gates Foundation Bets on This Biotech to Win the Zika Race (Hint, It's a Unicorn) 5/23/2017
3 Biotechs Bouncing Back After a Tough 2016 5/23/2017
Actelion (ALIOF.PK) Provides An Update On The Progress Towards Launching Idorsia - Key Results For Pipeline Assets To Be Developed By Idorsia 5/22/2017
5 Biotechs Releasing Highly-Anticipated Data at ASCO 5/22/2017
Merck & Co. (MRK)'s Immuno-Oncology Star Racks Up Two New Bladder Cancer Approvals 5/19/2017
Confident Johnson & Johnson (JNJ) Flexes Its Muscles, Plans 10 Blockbuster Approvals by 2021 5/18/2017
FDA Slaps Clinical Hold on Concert Pharma (CNCE)'s Hair Loss Drug 5/18/2017
Vesalius Raises €65 Million While Novartis AG (NVS) Alum's VC Seeks €50 Million to Bet on Italian Scientists 5/18/2017
Former Xontogeny CEO Emerges to Helm Newly-Launched $25 Million Biotech Startup Accelerator 5/18/2017
GlycoMimetics (GLYC) Stock Takes Off on Positive Phase II Leukemia Data, Breakthrough Tag 5/18/2017
Why Pfizer (PFE) May Need Another Big M&A for Growth 5/17/2017
3 Rock-Bottom Biotechs That Big Market Players are Betting On 5/17/2017
New FDA Head's First Order of Business: Inspection Staff Reorg and Lower Drug Prices 5/17/2017
Biogen (BIIB)'s CSO Quietly Leaves, But Will Still Get R&D Funding From the Biotech Giant 5/16/2017
With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO 5/16/2017
GlaxoSmithKline (GSK) Apparently Prepping to Buy Out Novartis Consumer Health Joint Venture Stake for $10.3 Billion 5/16/2017
Seattle's Genoa Pharma Banks $62 Million and Names a New CEO and CSO 5/16/2017
Biogen (BIIB) Exec Leaves to Put Together and Helm New Biotech Startup 5/15/2017
New York's Akari Puts CEO on Administrative Leave 5/15/2017
AstraZeneca PLC (AZN) Stock Hits 2017 High as Lung Cancer Med Reduces Death Risk in Phase III Study 5/15/2017
4 Cheapest Drug Stocks in the World 5/15/2017
Size Matters: Why a Biotech's Size Can Affect Your Career 5/12/2017
Top GlaxoSmithKline (GSK) Investor Cashes Out, Citing a Weak Pipeline and Lack of Strategic Options 5/12/2017
Interview Insider: Tips on How to Get Hired at Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), and Novartis AG (NVS) 5/12/2017
Top 5 Jobs for Introverted Life Scientists 5/12/2017
Pfizer (PFE) Makes a $545 Million Deal With Another Bay Area Biotech, Sangamo (SGMO) 5/12/2017
Daiichi Sankyo Abandons 6 Clinical Programs in Q1 Update 5/12/2017
Genentech (RHHBY)'s Top Cancer Prospect Flunks Phase III Test 5/12/2017
Another Top Sanofi Genzyme (SNY) Exec Jumps Ship 5/11/2017
4 Biotechs That Could Release Stock-Shattering Data Soon 5/11/2017
INC Research (INCR) Gobbles Up inVentiv Health (VTIV) in $4.6 Billion Deal 5/11/2017
PAREXEL (PRXL) to Slash Up to 1,200 Jobs Worldwide 5/11/2017
Daiichi Sankyo Adds The Source-To-Pay Catalyst From Zycus To Boost Its Procurement Performance 5/11/2017
Kite Pharma (KITE) Stock Plunges After Report of Patient Death in CAR-T Clinical Trial 5/10/2017
CRO Giant PAREXEL (PRXL) Explores $4 Billion Sale, Stock Jumps 5/10/2017
Pfizer (PFE) Sheds More After Unloading Medivation (MDVN)'s Mission Bay Space 5/10/2017
The Bay Area Biotech That Generates Billions in Cash Flow Every Year (So Far) 5/10/2017
Charles River  (CRL): Business Is Booming With 500 Positions Open 5/9/2017
This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG (NVS) 5/9/2017
3 Cancer Biotechs to Watch at ASCO 5/9/2017
3 Biotechs Predicted to Grow 415% and More in 2018 5/9/2017
Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ 5/8/2017
This New Threat Could Cause Gilead (GILD) to Hit Bottom 5/8/2017
Conspiracy Theory: Did Puma Biotech (PBYI) Exec Resign Because of Bad News Ahead? 5/8/2017
Don't Count Us Out: Pfizer (PFE) Hints at a Possible Bristol-Myers Squibb (BMY) Deal 5/5/2017
Gilead (GILD) Hints at 5-Point Comeback Strategy 5/5/2017
Booming Blueprint (BPMC) to Expand Into Former GlaxoSmithKline (GSK) Site 5/5/2017
This One Drugmaker Has Paid Dividends the Past 120+ Years 5/5/2017
Is This Fake News? Neurotrope (NTRP) Alzheimer's Release Takes Weird Spin 5/5/2017
Pfizer (PFE) Axes 3 Drugs From Pipeline in Q1 5/4/2017
This is What Shaved $3 Billion Off of GlaxoSmithKline (GSK)'s Market Cap Last Month 5/4/2017
This Booming Biotech Inks Huge Lease in the East Bay 5/3/2017
Lack of Cash Isn't a Concern for These 3 Clinical-Stage Biotechs 5/3/2017
3 Biotechs That Have Surged 150%+ During Trump's First 100 Days 5/3/2017
AstraZeneca PLC (AZN) Hits Milestone With Approval of Potential Bladder Cancer Blockbuster 5/3/2017
3 Safe and Solid Pharma Stocks for 2017 5/2/2017
GlaxoSmithKline (GSK) Injects $139 Million in Maryland Expansion 5/2/2017
Why M&A Hungry Sanofi (SNY) Could be Gearing Up to Buy Sarepta (SRPT) 5/2/2017
Wowsers! FDA Approves BioMarin (BMRN)'s Brineura, the First Drug for Batten Disease 5/2/2017
Takeda (TKPYY)'s $5 Billion Bet on Ariad (ARIA) Pays Off With Accelerated Approval of Lung Cancer Med 5/1/2017
This Is By Far the #1 Highest Paying Non-Executive Biotech Job in the U.S. 5/1/2017
Top 10 R&D Scientist Skills in Demand 5/1/2017
The Biotech Job Title You've Probably Never Heard Of 5/1/2017
M&A Speculation Begins as Sarepta (SRPT) CEO Puts in His Notice 4/28/2017
Genentech (RHHBY) Quietly Shelves Phase II Cancer Contender 4/28/2017
Mark Your Calendars: 4 Biotechs Facing FDA Decision Dates in May 4/28/2017
Analyzing Wild Optimism and Questionable Studies for Alzheimer’s Drug Development 4/28/2017
Another Biotech is Born as Bay Area's BridgeBio Pharma Launches Eidos Therapeutics With $27 Million 4/28/2017
The FDA Calls Pfizer (PFE)’s Next-Generation Lung Cancer Drug a Breakthrough 4/28/2017
And So It Begins: Covance (LH) Cuts 100+ Employees in Shut Down 4/27/2017
Some Predict Biogen (BIIB)’s Alzheimer’s Drug Will Fail 4/27/2017
Dropping Revenue: Expect More Cuts and Closures as LabCorp (LH) Aligns Covance (LH) Biz 4/26/2017
Why High-Flying M&A Target Tesaro (TSRO) Recently Lost More Than a Quarter of Its Value 4/26/2017
Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's 4/26/2017
Why Trump's Executive Order Could Rekindle M&A Feelings for Allergan (AGN), Pfizer (PFE) 4/26/2017
Gilead (GILD)'s $600 Million NASH Deal Finally Bears Fruit 4/26/2017
Embattled Marathon Pharma May Shutter Operations by May 1 4/26/2017
Rumor Mill: Johnson & Johnson (JNJ), Novartis AG (NVS) and Takeda (TKPYY) are All Making Googly Eyes at This Brazilian Drugmaker 4/26/2017
Fasten Your Seatbelt: Biogen (BIIB) Preps for a Deal-Making Bonanza 4/26/2017
How This Iowa Biotech Could be a Perfect Match for M&A Hungry Gilead (GILD) 4/25/2017
Why 90% of This $26 Billion Biotech's Sales Could be At Risk Within the Next 2 Years 4/24/2017
2 Biotech Players to Keep Your Eye On 4/24/2017
Immune Pharma CEO Steps Down to Lead R&D in Restructuring, May Spin Off Oncology Unit 4/24/2017
Former Pfizer (PFE) Cancer Scientist Gets All 5 Papers Retracted 4/24/2017
No Doubt: This is the Top Gene-Sequencing Stock to Buy This Year 4/21/2017
Facebook Gives Rare Peek Into Secretive Brain-Powered Tech Unit 4/21/2017
3 Intriguing Small-Cap Biotechs to Put on Your Watchlist 4/21/2017
Bay Area Startup Atomwise Offers a Compelling Deal to Scientists Hunting for New Drugs 4/21/2017
A Revealing Conversation With Booming Bay Area Biotech Relypsa (RLYP)’s President Scott Garland 4/20/2017
Exec Reveals Sanofi (SNY) is Hunting for M&As to Boost Diabetes Biz 4/20/2017
FDA's Shorten Review Time is a Bad Sign for Puma Biotech (PBYI)'s Controversial Cancer Drug 4/20/2017
It's Officially the End of the Road for Massachusetts Biotech Nuclea Biotechnologies 4/20/2017
How Pfizer (PFE) Made Most of Its $52.8 Billion Last Year 4/20/2017
Why Former Medivation (MDVN) CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant (AXON) 4/20/2017
Novartis AG (NVS) Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough 4/20/2017
Ex-Dendreon (DNDN) CEO Returns to Biotech, Throws a Lifeline to Struggling Nivalis (NVLS) 4/19/2017
Tech Giant Apple (AAPL) Hires Secret Team of Biomedical Engineers for Treating Diabetes 4/19/2017
How Biogen (BIIB) Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months 4/19/2017
Perrigo (PRGO) Shakes Up Exec Roster and Board, Hands Out a Fistful of Pink Slips 4/18/2017
New Biotech Incubator Emerges in Washington, Aims to Create Jobs and Hub Outside of Seattle 4/18/2017
FDA Just Rejected Eli Lilly (LLY), Incyte (INCY)'s Rheumatoid Arthritis Drug Baricitinib 4/18/2017
You'll Want to Own This Biotech Stock in the Next Market Crash 4/17/2017
From Biohacker to Organ Farmer, You Won’t Believe These Amazing 8 Biotech Jobs of the Future! 4/17/2017
Chiltern International Ltd. Explores Sale Valued at $1.3 Billion 4/17/2017
Top 10 Best Innovative Pharma Companies to Work For 4/14/2017
Proxy War Between Bay Area Innovia and Sarissa Heats Up, Could Mother of All Bombs Follow at Next Week’s Board Meeting? 4/14/2017
Bristol-Myers Squibb (BMY) Inks Two Separate Pacts With Biogen (BIIB) and Roche (RHHBY) For a Total of Up to $1.1B 4/14/2017
Nothing's Gonna Stop Neurocrine Biosciences (NBIX) Now: Shares Jumped on FDA Approval of the First and Only Drug to Treat Tardive Dyskinesia for Adults 4/13/2017
The Top 3 Best Computer Science Jobs in Biotechnology 4/13/2017
Why These 3 Drugmakers Could Buy Incyte (INCY) 4/13/2017
Massachusetts’ Lyndra Nabs $23 Million as It Plans to Start Clinical Trials This Year 4/13/2017
Why This Bay Area Biotech Stock Grew 415% in the Last Year 4/13/2017
Look Out, Another Biotech Joins San Diego With $40 Million and Will Take on NASH 4/13/2017
Why Roche (RHHBY) is a Hot Pick for Investors Right Now 4/13/2017
Strike It Rich With These 3 Biotech Stocks That Have Late-Stage Drugs 4/13/2017
Look Out Biotech! Google (GOOG)'s Parent Alphabet Sets Sights on Poaching Top Talent From Life Sciences and Healthcare 4/12/2017
Massachusetts Startup Frequency Therapeutics Nabs $32 Million 4/12/2017
What Happens if Gilead (GILD) Went Bigger Than Incyte (INCY) and Made a Play for This Pharma Giant 4/12/2017



//-->